{"id":323,"date":"2025-09-30T20:11:02","date_gmt":"2025-09-30T13:11:02","guid":{"rendered":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/"},"modified":"2025-09-30T20:11:02","modified_gmt":"2025-09-30T13:11:02","slug":"bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc","status":"publish","type":"post","link":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/","title":{"rendered":"Bagaimana Bimbingan RMAT Baru FDA Dampak Klinis, Strategi CMC"},"content":{"rendered":"<div>\n<div class=\"\">\n<div style=\"width:30%;float:left;max-width:525px;margin:0 1.5rem 1.5rem 0;clear:both;cursor:\" class=\" figure\">\n<div id=\"image-caption\" class=\"text-gray-500 italic\">\n<div class=\"blockText_blockContent__TbCXh\">\n<p class=\"pb-2\">Molekul DNA helix ganda dengan gen yang dimodifikasi, mengoreksi mutasi dengan rekayasa genetika | Kredit Gambar: \u00a9 Nobeastsofierce &#8211; Stock.adobe.com<\/p>\n<\/div>\n<\/div>\n<div class=\"hidden top-(-100%) block w-(1px) transition-opacity duration-500 ease-in-out opacity-0 overflow-hidden\"><img decoding=\"async\" class=\"m-auto absolute inset-0 max-w-(0%) max-h-(0%) border-(3px) border-solid border-white shadow-(0px_0px_8px_rgba(0,0,0,0.3)) box-border transition ease-in-out duration-500\" src=\"https:\/\/cdn.sanity.io\/images\/0vv8moc6\/pharmtech\/6a88d048c569754d1a9f0b1e82955c2249bd0551-5000x3749.jpg?fit=crop&amp;auto=format\"\/><\/div>\n<\/div>\n<\/div>\n<p class=\"pb-2\">FDA telah mengeluarkan rancangan panduan baru untuk industri, \u201cProgram yang dipercepat untuk terapi obat regeneratif untuk kondisi serius,\u201d yang bertujuan untuk memberikan sponsor yang terlibat dalam pengembangan terapi tersebut dengan rekomendasi berdasarkan bagian -bagian tertentu dari undang -undang yang sebelumnya yang ada, seperti Undang -Undang Pangan Federal (1).<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Singkatnya, apa arti panduan rancangan ini?<\/strong><\/h2>\n<p class=\"pb-2\">Di bawah bagian 506 (g) dari Undang -Undang FD&#038;C, menurut rancangan yang dipublikasikan oleh FDA pada 25 September 2025, terapi obat regeneratif dapat ditetapkan sebagai terapi lanjutan regeneratif, yang kemudian disebut FDA sebagai &#8220;terapi lanjutan obat regeneratif&#8221; (RMAT), jika kriteria tertentu dipenuhi (1).<\/p>\n<p class=\"pb-2\">Program yang dipercepat tersedia untuk sponsor terapi yang dirancang untuk mengobati penyakit atau kondisi yang serius atau mengancam jiwa, status RMAT di antara mereka (1). Penunjukan FDA lainnya dalam vena ini termasuk jalur cepat, terapi terobosan, tinjauan prioritas, dan persetujuan yang dipercepat.<\/p>\n<p class=\"pb-2\">Rancangan pedoman, secara umum, berkaitan dengan terapi obat regeneratif yang diatur sebagai biologi, di bawah Undang -Undang FD&#038;C, oleh Pusat Evaluasi dan Penelitian dan Penelitian Biologi FDA (CBER) (1).<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Apakah panduan tersebut memberikan fleksibilitas dalam pengembangan klinis?<\/strong><\/h2>\n<p class=\"pb-2\">FDA menyatakan bahwa CBER akan mempertimbangkan uji coba yang menggabungkan desain adaptif, strategi pengayaan, dan titik akhir baru, memberikan sebagai contoh bidang gangguan penglihatan lanjut. Di sini, peningkatan visi fungsional bisa menjadi titik akhir yang dapat diterima, menurut draft (1). Sebagai contoh lain, untuk produk penggantian jaringan, kinerja jangka pendek dapat dianggap sebagai titik akhir yang bermakna secara klinis.<\/p>\n<p class=\"pb-2\">Untuk produk yang ditunjuk RMAT, panduan merinci jalur untuk persetujuan yang dipercepat berdasarkan pengganti atau titik akhir menengah yang cukup mungkin untuk memprediksi manfaat klinis jangka panjang (1). Panduan ini menentukan bahwa sponsor mungkin dapat menggunakan bukti klinis dari pendaftar pasien, catatan kesehatan elektronik, atau sumber lain dari bukti dunia nyata sebagai pengganti uji coba konfirmasi tradisional.<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Apakah ada terapi catatan yang menerima penunjukan RMAT baru -baru ini?<\/strong><\/h2>\n<p class=\"pb-2\">Pada Juli 2025, perusahaan bioteknologi tahap klinis Genascence Corporation mengumumkan bahwa potensi terapi gen kelas pertama yang menghalangi Interleukin 1 untuk pengobatan osteoartritis lutut diberikan penunjukan RMAT, setelah FDA sebelumnya memberikan penunjukan cepat terapi pada 2024 (2).<\/p>\n<p class=\"pb-2\">Perusahaan tahap klinis kedua, Veongen Therapeutics, kemudian mengumumkan pada Agustus 2025 bahwa FDA memberikan status RMAT kepada VG801, terapi gen investigasi timbal Veongen untuk penyakit Stargardt dan distrofi retina lainnya yang terkait dengan mutasi pada gen ABCA4 (3).<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Bagaimana dengan pertimbangan kimia, manufaktur, dan kontrol (CMC)?<\/strong><\/h2>\n<p class=\"pb-2\">Panduan ini memperjelas bahwa jadwal klinis yang dipercepat tidak boleh mengurangi standar CMC yang diperlukan untuk persetujuan (1). Sponsor harus memberikan informasi CMC yang cukup untuk memastikan kualitas produk, termasuk identitas, kemurnian, dan kekuatan. Dokumen ini mengakui tantangan unik untuk menyelaraskan pengembangan produk yang cepat dengan program klinis yang lebih cepat untuk terapi regeneratif.<\/p>\n<p class=\"pb-2\">Panduan ini menekankan pentingnya interaksi dini dan sering dengan Kantor Produk Terapi CBER untuk secara proaktif mengatasi tantangan manufaktur. Untuk penunjukan RMAT, bukti klinis awal harus dihasilkan dengan produk yang sebanding dengan yang dimaksudkan untuk pengembangan tahap selanjutnya, menggarisbawahi kebutuhan untuk data perbandingan yang kuat ketika perubahan manufaktur terjadi (1).<\/p>\n<p class=\"pb-2\">Periode komentar untuk rancangan panduan terbuka hingga 24 November 2025 (4).<\/p>\n<h2 class=\"text-2xl pb-4 pt-2\"><strong>Referensi<\/strong><\/h2>\n<p class=\"pb-2\">1. FDA, <em>Draft pedoman untuk industri, program yang dipercepat untuk terapi obat regeneratif untuk kondisi serius<\/em> (CBER\/OTP, September 2025).<br \/>2. Haigney, S. FDA memberikan obat regeneratif terapi lanjutan untuk terapi gen untuk lutut OA. <em>Biopharminternational.com<\/em>18 Juli 2025.<br \/>3. Lavery, Terapi Gen Penyakit Stargardt P. Veongen mendapat status FDA RMAT. <em>Biopharminternational.com<\/em>22 Agustus 2025.<br \/>4. FDA, \u201cProgram yang Dipercepat untuk Terapi Kedokteran Regeneratif Untuk Kondisi Serius; Draf Bimbingan untuk Industri; Ketersediaan,\u201d Pemberitahuan, <em>Daftar Federal<\/em>90 FR 46225, 46225\u201346227.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Molekul DNA helix ganda dengan gen yang dimodifikasi, mengoreksi mutasi dengan rekayasa genetika | Kredit Gambar: \u00a9 Nobeastsofierce &#8211; Stock.adobe.com FDA telah mengeluarkan rancangan panduan baru untuk industri, \u201cProgram yang dipercepat untuk terapi obat regeneratif untuk kondisi serius,\u201d yang bertujuan untuk memberikan sponsor yang terlibat dalam pengembangan terapi tersebut dengan rekomendasi berdasarkan bagian -bagian tertentu [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":324,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-323","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bagaimana Bimbingan RMAT Baru FDA Dampak Klinis, Strategi CMC - Nova Anggreni, S.Farm, APT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/\" \/>\n<meta property=\"og:locale\" content=\"id_ID\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bagaimana Bimbingan RMAT Baru FDA Dampak Klinis, Strategi CMC - Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"og:description\" content=\"Molekul DNA helix ganda dengan gen yang dimodifikasi, mengoreksi mutasi dengan rekayasa genetika | Kredit Gambar: \u00a9 Nobeastsofierce &#8211; Stock.adobe.com FDA telah mengeluarkan rancangan panduan baru untuk industri, \u201cProgram yang dipercepat untuk terapi obat regeneratif untuk kondisi serius,\u201d yang bertujuan untuk memberikan sponsor yang terlibat dalam pengembangan terapi tersebut dengan rekomendasi berdasarkan bagian -bagian tertentu [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/\" \/>\n<meta property=\"og:site_name\" content=\"Nova Anggreni, S.Farm, APT\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-30T13:11:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cdn.sanity.io\/images\/0vv8moc6\/pharmtech\/6a88d048c569754d1a9f0b1e82955c2249bd0551-5000x3749.jpg?fit=crop&amp;auto=format\" \/>\n<meta name=\"author\" content=\"pythonsonline\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ditulis oleh\" \/>\n\t<meta name=\"twitter:data1\" content=\"pythonsonline\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimasi waktu membaca\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 menit\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/\"},\"author\":{\"name\":\"pythonsonline\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\"},\"headline\":\"Bagaimana Bimbingan RMAT Baru FDA Dampak Klinis, Strategi CMC\",\"datePublished\":\"2025-09-30T13:11:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/\"},\"wordCount\":582,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/09\/6a88d048c569754d1a9f0b1e82955c2249bd0551-5000x3749-scaled.jpg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/\",\"url\":\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/\",\"name\":\"Bagaimana Bimbingan RMAT Baru FDA Dampak Klinis, Strategi CMC - Nova Anggreni, S.Farm, APT\",\"isPartOf\":{\"@id\":\"https:\/\/pythonsonline.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/09\/6a88d048c569754d1a9f0b1e82955c2249bd0551-5000x3749-scaled.jpg\",\"datePublished\":\"2025-09-30T13:11:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#breadcrumb\"},\"inLanguage\":\"id\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#primaryimage\",\"url\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/09\/6a88d048c569754d1a9f0b1e82955c2249bd0551-5000x3749-scaled.jpg\",\"contentUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/09\/6a88d048c569754d1a9f0b1e82955c2249bd0551-5000x3749-scaled.jpg\",\"width\":2560,\"height\":1919},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Beranda\",\"item\":\"https:\/\/pythonsonline.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bagaimana Bimbingan RMAT Baru FDA Dampak Klinis, Strategi CMC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pythonsonline.com\/#website\",\"url\":\"https:\/\/pythonsonline.com\/\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"description\":\"Keahlian Farmasi Bertemu Kekuatan Python\",\"publisher\":{\"@id\":\"https:\/\/pythonsonline.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pythonsonline.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"id\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/pythonsonline.com\/#organization\",\"name\":\"Nova Anggreni, S.Farm, APT\",\"url\":\"https:\/\/pythonsonline.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"contentUrl\":\"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png\",\"width\":1080,\"height\":416,\"caption\":\"Nova Anggreni, S.Farm, APT\"},\"image\":{\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156\",\"name\":\"pythonsonline\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"id\",\"@id\":\"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g\",\"caption\":\"pythonsonline\"},\"sameAs\":[\"https:\/\/pythonsonline.com\"],\"url\":\"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bagaimana Bimbingan RMAT Baru FDA Dampak Klinis, Strategi CMC - Nova Anggreni, S.Farm, APT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/","og_locale":"id_ID","og_type":"article","og_title":"Bagaimana Bimbingan RMAT Baru FDA Dampak Klinis, Strategi CMC - Nova Anggreni, S.Farm, APT","og_description":"Molekul DNA helix ganda dengan gen yang dimodifikasi, mengoreksi mutasi dengan rekayasa genetika | Kredit Gambar: \u00a9 Nobeastsofierce &#8211; Stock.adobe.com FDA telah mengeluarkan rancangan panduan baru untuk industri, \u201cProgram yang dipercepat untuk terapi obat regeneratif untuk kondisi serius,\u201d yang bertujuan untuk memberikan sponsor yang terlibat dalam pengembangan terapi tersebut dengan rekomendasi berdasarkan bagian -bagian tertentu [&hellip;]","og_url":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/","og_site_name":"Nova Anggreni, S.Farm, APT","article_published_time":"2025-09-30T13:11:02+00:00","og_image":[{"url":"https:\/\/cdn.sanity.io\/images\/0vv8moc6\/pharmtech\/6a88d048c569754d1a9f0b1e82955c2249bd0551-5000x3749.jpg?fit=crop&amp;auto=format","type":"","width":"","height":""}],"author":"pythonsonline","twitter_card":"summary_large_image","twitter_misc":{"Ditulis oleh":"pythonsonline","Estimasi waktu membaca":"3 menit"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#article","isPartOf":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/"},"author":{"name":"pythonsonline","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156"},"headline":"Bagaimana Bimbingan RMAT Baru FDA Dampak Klinis, Strategi CMC","datePublished":"2025-09-30T13:11:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/"},"wordCount":582,"commentCount":0,"publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"image":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#primaryimage"},"thumbnailUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/09\/6a88d048c569754d1a9f0b1e82955c2249bd0551-5000x3749-scaled.jpg","articleSection":["Blog"],"inLanguage":"id","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/","url":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/","name":"Bagaimana Bimbingan RMAT Baru FDA Dampak Klinis, Strategi CMC - Nova Anggreni, S.Farm, APT","isPartOf":{"@id":"https:\/\/pythonsonline.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#primaryimage"},"image":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#primaryimage"},"thumbnailUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/09\/6a88d048c569754d1a9f0b1e82955c2249bd0551-5000x3749-scaled.jpg","datePublished":"2025-09-30T13:11:02+00:00","breadcrumb":{"@id":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#breadcrumb"},"inLanguage":"id","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/"]}]},{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#primaryimage","url":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/09\/6a88d048c569754d1a9f0b1e82955c2249bd0551-5000x3749-scaled.jpg","contentUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/09\/6a88d048c569754d1a9f0b1e82955c2249bd0551-5000x3749-scaled.jpg","width":2560,"height":1919},{"@type":"BreadcrumbList","@id":"https:\/\/pythonsonline.com\/index.php\/2025\/09\/30\/bagaimana-bimbingan-rmat-baru-fda-dampak-klinis-strategi-cmc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Beranda","item":"https:\/\/pythonsonline.com\/"},{"@type":"ListItem","position":2,"name":"Bagaimana Bimbingan RMAT Baru FDA Dampak Klinis, Strategi CMC"}]},{"@type":"WebSite","@id":"https:\/\/pythonsonline.com\/#website","url":"https:\/\/pythonsonline.com\/","name":"Nova Anggreni, S.Farm, APT","description":"Keahlian Farmasi Bertemu Kekuatan Python","publisher":{"@id":"https:\/\/pythonsonline.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pythonsonline.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"id"},{"@type":"Organization","@id":"https:\/\/pythonsonline.com\/#organization","name":"Nova Anggreni, S.Farm, APT","url":"https:\/\/pythonsonline.com\/","logo":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/","url":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","contentUrl":"https:\/\/pythonsonline.com\/wp-content\/uploads\/2025\/04\/novapylogo.png","width":1080,"height":416,"caption":"Nova Anggreni, S.Farm, APT"},"image":{"@id":"https:\/\/pythonsonline.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/c1dd578cabc4e398492d9e25f7aff156","name":"pythonsonline","image":{"@type":"ImageObject","inLanguage":"id","@id":"https:\/\/pythonsonline.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ce18169fbfa6b96654e8a84f663d2fe6cd783a46c25e8318605272fd245c2e8c?s=96&d=mm&r=g","caption":"pythonsonline"},"sameAs":["https:\/\/pythonsonline.com"],"url":"https:\/\/pythonsonline.com\/index.php\/author\/pythonsonline\/"}]}},"_links":{"self":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/comments?post=323"}],"version-history":[{"count":0,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/posts\/323\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/media\/324"}],"wp:attachment":[{"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/media?parent=323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/categories?post=323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pythonsonline.com\/index.php\/wp-json\/wp\/v2\/tags?post=323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}